Bristol-Myers Squibb Co (NYSE:BMY) shares, rose in value on Thursday, February 13, with the stock price down by -0.32% to the previous day’s close as strong demand from buyers drove the stock to $55.97.
Actively observing the price movement in the last trading, the stock closed the session at $56.15. Referring to stock’s 52-week performance, its high was $61.10, and the low was $39.35. On the whole, BMY has fluctuated by 0.41% over the past month.
With the market capitalization of Bristol-Myers Squibb Co currently standing at about $113.52 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March. The company’s Forward Dividend Ratio is 2.42, with its dividend yield at 4.32%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 45.7B, with a low estimate of 10.01B and a high estimate of 11.09B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 10.7B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that BMY’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of BMY currently trading nearly -3.40% and -2.63% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.62, while the 7-day volatility ratio is showing 2.43% which for the 30-day chart, stands at 2.40%. Furthermore, Bristol-Myers Squibb Co (BMY)’s beta value is 0.44, and its average true range (ATR) is 1.35.
A comparison of Bristol-Myers Squibb Co (BMY) with its peers suggests the former has fared considerably weaker in the market. BMY showed an intraday change of -0.32% in last session, and over the past year, it grew by 12.50%%.
Data on historical trading for Bristol-Myers Squibb Co (NYSE:BMY) indicates that the trading volumes over the past 3 months, they’ve averaged 10.94 million. According to company’s latest data on outstanding shares, there are 2.03 billion shares outstanding.
Nearly 0.08% of Bristol-Myers Squibb Co’s shares belong to company insiders and institutional investors own 79.07% of the company’s shares. The stock has fallen by -1.04% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BMY stock heading into the next quarter.
